logo-loader
viewLexagene Holdings Inc

Lexagene set to go to market with their Pathogen Detection System

LexaGene Holdings Inc. (CVE_LXG) President Daryl Rebeck joined Proactive Investors in San Francisco with news their Pathogen Detection System will be available to market by 2019.

Rebeck also told Proactive about some of the many consumers who can benefit from the technology, including hospitals and veterinarians.
 

Quick facts: Lexagene Holdings Inc

Price: 0.54 CAD

TSX-V:LXG
Market: TSX-V
Market Cap: $46.26 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Lexagene Holdings Inc named herein, including the promotion by the Company of Lexagene Holdings Inc in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Lexagene Develops technology to test for deadly mosquito...

Lexagene (CVE: LXG-OTCQB-LXXGF) Founder and CEO Dr jack Regan joined Steve Darling from Proactive Vancouver on Skype with news the company has used their proprietary technology to develop a detection system for the Eastern Equine Encephalitis or EEE. Regan says that not only can they use the...

on 17/9/19

2 min read